Company: REVB
Filing Date: 2025-05-23
Form Type: CORRESP
Source: 0001213900-25-047306
Chunk: 0

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-23
Form: CORRESP
Chunk 0
---
<div align='center'>J.P. Galda & Co.

40 East Montgomery Avenue, LTW 220

Ardmore, Pennsylvania 19008</div>

May 23, 2025

VIA EDGAR AND E-MAIL

Mr. Alan Campbell

Mr. Joseph McCann

Office of Life Sciences

Division of Corporate Finance

U.S. Securities and Exchange Commission

100 F. Street, N.E.

Washington, DC 20549-7010

Re: Revelation Biosciences, Inc. Registration Statement on Form S-1

Commission File No. 333-287423

Gentlemen:

This letter will confirm my conversation with Mr. McCann to the effect
that we are not individually responding to the Staff’s letter of comments on the above-captioned Registration Statement because
the transaction has been restructured to eliminate the zero exercise price warrants and the Class H-3 Common Stock Warrants, thereby rendering
such comments no longer applicable.

Very truly yours,

/s/ Joseph P. Galda